Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah FarmerCancer Research UK Gene Function and Regulation Group, London, UKNuala McCabeCancer Research UK Gene Function and Regulation Group,Christopher J. LordBreast Cancer NowAndrew TuttGuy's Hospital, St Thomas' Street, SE1 9RT, London, UKDamian A. JohnsonThe Breakthrough Breast Cancer Research Centre Institute of Cancer Research, Fulham Road, SW3 6JB, London, UKTobias B. RichardsonThe Breakthrough Breast Cancer Research Centre Institute of Cancer Research, Fulham Road, SW3 6JB, London, UKManuela SantarosaThe Breakthrough Breast Cancer Research Centre Institute of Cancer Research, Fulham Road, SW3 6JB, London, UKKrystyna J. DillonKuDOS Pharmaceuticals Ltd, Cambridge Science Park, Cambridge, CB4 0WG, UKIan HicksonKuDOS Pharmaceuticals Ltd, Cambridge Science Park, Cambridge, CB4 0WG, UKCharlotte KnightsKuDOS Pharmaceuticals Ltd, Cambridge Science Park, Cambridge, CB4 0WG, UKNiall M.B. MartinKuDOS Pharmaceuticals Ltd, Cambridge Science Park, Cambridge, CB4 0WG, UKStephen P. JacksonKuDOS Pharmaceuticals Ltd, Cambridge Science Park, Cambridge, CB4 0WG, UKGraeme C.M. SmithKuDOS Pharmaceuticals Ltd, Cambridge Science Park, Cambridge, CB4 0WG, UKAlan AshworthCancer Research UK Gene Function and Regulation Group,
2005en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0